Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases.

Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases.
复制标题

Sestrin 2作为调节代谢相关疾病的潜在靶点。

DOI:
10.3389/fendo.2021.751020
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Zhang Z
Zhang Z
中科院分区:
医学2区
文献类型:
--
作者:
Gong L;Wang Z;Wang Z;Zhang Z

文献摘要

参考文献

被引文献

相似文献

Sestrin2 是一种高度保守的蛋白质,可在多种应激条件下被诱导,包括 DNA 损伤、氧化应激、内质网 (ER) 应激和代谢应激。大量研究表明,AMP激活蛋白激酶(AMPK)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路在代谢调节中具有至关重要的作用。 Sestrin2 通过多种途径调节代谢,包括激活 AMPK、抑制 mTOR 复合物 1 (mTORC1)、激活 mTOR 复合物 2 (mTORC2)、抑制 ER 应激和促进自噬。因此,调节Sestrin2活性可能为预防胰岛素抵抗、糖尿病、肥胖、非酒精性脂肪肝和心肌缺血/再灌注损伤等代谢性疾病提供潜在的治疗靶点。在这篇综述中,我们研究了Sestrin2与AMPK/mTOR信号通路之间的调节关系以及Sestrin2对能量代谢的影响。
Sestrin2 is a highly conserved protein that can be induced under a variety of stress conditions, including DNA damage, oxidative stress, endoplasmic reticulum (ER) stress, and metabolic stress. Numerous studies have shown that the AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) signaling pathway has a crucial role in the regulation of metabolism. Sestrin2 regulates metabolism via a number of pathways, including activation of AMPK, inhibition of the mTOR complex 1 (mTORC1), activation of mTOR complex 2 (mTORC2), inhibition of ER stress, and promotion of autophagy. Therefore, modulation of Sestrin2 activity may provide a potential therapeutic target for the prevention of metabolic diseases such as insulin resistance, diabetes, obesity, non-alcoholic fatty liver disease, and myocardial ischemia/reperfusion injury. In this review, we examined the regulatory relationship between Sestrin2 and the AMPK/mTOR signaling pathway and the effects of Sestrin2 on energy metabolism.
DOI: 10.1016/j.celrep.2014.09.014
发表时间: 2014-10-09
期刊: Cell reports
影响因子: 8.8
作者:
Chantranupong L;Wolfson RL;Orozco JM;Saxton RA;Scaria SM;Bar-Peled L;Spooner E;Isasa M;Gygi SP;Sabatini DM
通讯作者: Sabatini DM
DOI: 10.1056/nejm199907223410404
发表时间: 1999-07-22
影响因子: 158.5
作者:
Cline, GW;Petersen, KF;Shulman, GI
通讯作者: Shulman, GI
DOI: 10.1002/emmm.201000097
发表时间: 2010-10
影响因子: 11.1
作者:
Budanou, Andrei V.;Lee, Jun Hee;Karin, Michael
通讯作者: Karin, Michael
DOI: 10.1038/sj.onc.1205877
发表时间: 2002-09-05
期刊: ONCOGENE
影响因子: 8
作者:
Budanov, AV;Shoshani, T;Feinstein, E
通讯作者: Feinstein, E
DOI: 10.1038/srep22538
发表时间: 2016-03-02
期刊: Scientific reports
影响因子: 4.6
作者:
Ding B;Parmigiani A;Divakaruni AS;Archer K;Murphy AN;Budanov AV
通讯作者: Budanov AV